274 related articles for article (PubMed ID: 20534517)
1. A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors.
Du J; Wei Y; Liu L; Wang Y; Khairova R; Blumenthal R; Tragon T; Hunsberger JG; Machado-Vieira R; Drevets W; Wang YT; Manji HK
Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11573-8. PubMed ID: 20534517
[TBL] [Abstract][Full Text] [Related]
2. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
3. Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.
Valvassori SS; Dal-Pont GC; Resende WR; Jornada LK; Peterle BR; Machado AG; Farias HR; de Souza CT; Carvalho AF; Quevedo J
Neuropharmacology; 2017 May; 117():447-459. PubMed ID: 27789311
[TBL] [Abstract][Full Text] [Related]
4. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.
Silva R; Mesquita AR; Bessa J; Sousa JC; Sotiropoulos I; Leão P; Almeida OF; Sousa N
Neuroscience; 2008 Mar; 152(3):656-69. PubMed ID: 18291594
[TBL] [Abstract][Full Text] [Related]
5. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test.
Gould TD; Einat H; Bhat R; Manji HK
Int J Neuropsychopharmacol; 2004 Dec; 7(4):387-90. PubMed ID: 15315719
[TBL] [Abstract][Full Text] [Related]
6. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.
Kozikowski AP; Gaisina IN; Yuan H; Petukhov PA; Blond SY; Fedolak A; Caldarone B; McGonigle P
J Am Chem Soc; 2007 Jul; 129(26):8328-32. PubMed ID: 17552518
[TBL] [Abstract][Full Text] [Related]
8. Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha.
Kirshenboim N; Plotkin B; Shlomo SB; Kaidanovich-Beilin O; Eldar-Finkelman H
J Mol Neurosci; 2004; 24(2):237-45. PubMed ID: 15456937
[TBL] [Abstract][Full Text] [Related]
9. 3'-Deoxyadenosine (Cordycepin) Produces a Rapid and Robust Antidepressant Effect via Enhancing Prefrontal AMPA Receptor Signaling Pathway.
Li B; Hou Y; Zhu M; Bao H; Nie J; Zhang GY; Shan L; Yao Y; Du K; Yang H; Li M; Zheng B; Xu X; Xiao C; Du J
Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26443809
[TBL] [Abstract][Full Text] [Related]
10. Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression.
Du J; Gray NA; Falke CA; Chen W; Yuan P; Szabo ST; Einat H; Manji HK
J Neurosci; 2004 Jul; 24(29):6578-89. PubMed ID: 15269270
[TBL] [Abstract][Full Text] [Related]
11. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
[TBL] [Abstract][Full Text] [Related]
12. The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: A review of the literature.
Costemale-Lacoste JF; Guilloux JP; Gaillard R
Encephale; 2016 Apr; 42(2):156-64. PubMed ID: 26995153
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase-3β inhibition prevents remifentanil-induced postoperative hyperalgesia via regulating the expression and function of AMPA receptors.
Li YZ; Tang XH; Wang CY; Hu N; Xie KL; Wang HY; Yu YH; Wang GL
Anesth Analg; 2014 Oct; 119(4):978-987. PubMed ID: 25126703
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania.
Prickaerts J; Moechars D; Cryns K; Lenaerts I; van Craenendonck H; Goris I; Daneels G; Bouwknecht JA; Steckler T
J Neurosci; 2006 Aug; 26(35):9022-9. PubMed ID: 16943560
[TBL] [Abstract][Full Text] [Related]
15. Ketamine-induced inhibition of glycogen synthase kinase-3 contributes to the augmentation of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor signaling.
Beurel E; Grieco SF; Amadei C; Downey K; Jope RS
Bipolar Disord; 2016 Sep; 18(6):473-480. PubMed ID: 27687706
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks.
Padiath QS; Paranjpe D; Jain S; Sharma VK
Chronobiol Int; 2004 Jan; 21(1):43-55. PubMed ID: 15129823
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cells.
Yeste-Velasco M; Folch J; Trullàs R; Abad MA; Enguita M; Pallàs M; Camins A
Neuropharmacology; 2007 Aug; 53(2):295-307. PubMed ID: 17612578
[TBL] [Abstract][Full Text] [Related]
18. Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo.
Manser C; Guillot F; Vagnoni A; Davies J; Lau KF; McLoughlin DM; De Vos KJ; Miller CC
Oncogene; 2012 May; 31(22):2773-82. PubMed ID: 21996745
[TBL] [Abstract][Full Text] [Related]
19. Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades.
Wada A
J Pharmacol Sci; 2009 May; 110(1):14-28. PubMed ID: 19423950
[TBL] [Abstract][Full Text] [Related]
20. Glycogen Synthase Kinase 3β-mediated Phosphorylation in the Most C-terminal Region of Protein Interacting with C Kinase 1 (PICK1) Regulates the Binding of PICK1 to Glutamate Receptor Subunit GluA2.
Yagishita S; Murayama M; Ebihara T; Maruyama K; Takashima A
J Biol Chem; 2015 Dec; 290(49):29438-48. PubMed ID: 26472923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
